Atrial Fibrillation Trial, Recruiting NCT07002450 Sponsor: Ottawa Heart Institute Research Corporation Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07002450
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have atrial fibrillation (an irregular heartbeat) that causes symptoms and is not caused by a temporary or treatable condition such as an infection, a blood clot in the lungs, or an overactive thyroid
  • People whose doctors, following local medical guidelines, require a scan of the heart's left upper chamber before performing a procedure to restore normal heart rhythm

Who may not be able to join:

  • People who need an urgent, emergency procedure to restore their heart rhythm right away — for example, those with dangerously low blood pressure, signs of shock, severe ongoing chest pain, significant heart rhythm changes on an electrical heart tracing, or serious breathing difficulties due to fluid in the lungs
  • People for whom a particular type of CT heart scan (called cardiac CT) is not safe — for example, those with poorly functioning kidneys (confirm with trial site for exact levels), an allergy to the dye used in CT scans, those who are pregnant, or those who are unable to hold their breath for around 20 seconds

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benjamin Chow, MD PhD FRCPC FACC FESC FA, Ottawa Heart Institute Research Corporation

Phone: 613-696-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ottawa Heart Institute Research Corporation
Registry
ClinicalTrials.gov
Start date
15 June 2025
Est. completion
15 June 2028

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Primary composite outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov